Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEUPROLIDE vs LEVETIRACETAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEUPROLIDE vs LEVETIRACETAM: Safety Overview

Metric LEUPROLIDE LEVETIRACETAM
Total FAERS Reports 70,893 62,552
Deaths Reported 11,858 4,322
Death Rate 16.7% 6.9%
Hospitalizations 10,499 19,165
Average Patient Age 67.5 yrs 40.6 yrs
% Female Patients 14.1% 54.9%
FDA Approval Date Apr 14, 2023 Apr 11, 2012
Manufacturer TOLMAR Inc. SOHM, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Prescription